“…The reliability and high discriminatory potential of DNA fingerprinting suggest its use in bacteriological epidemiology. In conjunction with sero- [6], phage [13], pyocin typing [14] and the DNA probing of hypervariable genomic sites [15] the genome fingerprinting of P. aeruginosa strains may be employed to investigate outbreaks of nosocomial infection and to aid effective infection control, e.g., in cystic fibrosis, the chronic P. aeruginosa infection of the lungs is primarily responsible for pulmonary deterioration and reduced life expectancy [16]. Using DNA fingerprinting, we were able to detect cross-infection with P. aeruginosa strains among siblings with cystic fibrosis, to monitor the acquisition and genomic variations of strains during the course of the disease, and to follow the spread and transmission of organisms in hospital wards (manuscript in preparation).…”